4.7 Article

New horizons in the pathogenesis, assessment and management of delirium

期刊

AGE AND AGEING
卷 42, 期 6, 页码 667-674

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ageing/aft148

关键词

delirium; older people; delirium pathogenesis; delirium assessment; delirium management

资金

  1. BBSRC
  2. EPSRC
  3. ESRC
  4. MRC
  5. Wellcome Trust Clinical Fellowship
  6. Research into Ageing Fund [367]
  7. Age UK
  8. British Geriatrics Society
  9. Dunhill Medical Trust [RTF17/0111]
  10. Research into Ageing
  11. British Geriatrics Society [342]
  12. Wellcome Trust
  13. MRC [MC_G0900869] Funding Source: UKRI
  14. Medical Research Council [MR/K026992/1, MC_G0900869] Funding Source: researchfish
  15. The Dunhill Medical Trust [RTF17/0111] Funding Source: researchfish

向作者/读者索取更多资源

Delirium is one of the foremost unmet medical needs in healthcare. It affects one in eight hospitalised patients and is associated with multiple adverse outcomes including increased length of stay, new institutionalisation, and considerable patient distress. Recent studies also show that delirium strongly predicts future new-onset dementia, as well as accelerating existing dementia. The importance of delirium is now increasingly being recognised, with a growing research base, new professional international organisations, increased interest from policymakers, and greater prominence of delirium in educational and audit programmes. Nevertheless, the field faces several complex research and clinical challenges. In this article we focus on selected areas of recent progress and/or uncertainty in delirium research and practice. (i) Pathogenesis: recent studies in animal models using peripheral inflammatory stimuli have begun to suggest mechanisms underlying the delirium syndrome as well as its link with dementia. A growing body of blood and cerebrospinal fluid studies in humans have implicated inflammatory and stress mediators. (ii) Prevention: delirium prevention is effective in the context of research studies, but there are several unresolved issues, including what components should be included, the role of prophylactic drugs, and the overlap with general best care for hospitalised older people. (iii) Assessment: though there are several instruments for delirium screening and assessment, detection rates remain dismal. There are no clear solutions but routine screening embedded into clinical practice, and the development of new rapid screening instruments, offer potential. (iv) Management: studies are difficult given the heterogeneity of delirium and currently expert and comprehensive clinical care remains the main recommendation. Future studies may address the role of drugs for specific elements of delirium. In summary, though facing many challenges, the field continues to make progress, with several promising lines of enquiry and an expanding base of interest among researchers, clinicians and policymakers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据